Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

This analysis was conducted to assess exposure–response relationships for efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor. Efficacy was assessed categorically by overall response rate (ORR) with Response Evaluation Criteria in Solid Tumors version 1.1 and longitudi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Ophelia, Zahir, Hamim, French, Jonathan, Polhamus, Daniel, Wang, Xiaoning, van de Sande, Michiel, Tap, William D., Gelderblom, Hans, Wagner, Andrew J., Healey, John H., Greenberg, Jonathan, Shuster, Dale, Stacchiotti, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592513/
https://www.ncbi.nlm.nih.gov/pubmed/34585528
http://dx.doi.org/10.1002/psp4.12712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592513/
https://www.ncbi.nlm.nih.gov/pubmed/34585528
http://dx.doi.org/10.1002/psp4.12712

Ejemplares similares